The browser you are using is not supported by this website. All versions of Internet Explorer are no longer supported, either by us or Microsoft (read more here: https://www.microsoft.com/en-us/microsoft-365/windows/end-of-ie-support).

Please use a modern browser to fully experience our website, such as the newest versions of Edge, Chrome, Firefox or Safari etc.

Default user image.

Jan Apelqvist

Physician

Default user image.

The Cost-effectiveness of Treating Diabetic Lower Extremity Ulcers with Becaplermin (Regranex): A Core Model with an Application Using Swedish Cost Data.

Author

  • U Persson
  • M Willis
  • K Odegaard
  • Jan Apelqvist

Department/s

  • Genomics, Diabetes and Endocrinology

Publishing year

2000

Language

English

Pages

39-46

Publication/Series

Value in Health

Volume

3 Suppl 1

Document type

Journal article

Publisher

Wiley-Blackwell

Topic

  • Health Care Service and Management, Health Policy and Services and Health Economy

Status

Published

Research group

  • Genomics, Diabetes and Endocrinology

ISBN/ISSN/Other

  • ISSN: 1098-3015